AMFR anticorps (C-Term)
Aperçu rapide pour AMFR anticorps (C-Term) (ABIN629722)
Antigène
Voir toutes AMFR AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- AMFR antibody was raised against the C terminal of AMFR
-
Purification
- Purified
-
Immunogène
- AMFR antibody was raised using the C terminal of AMFR corresponding to a region with amino acids FGEVEVEPSEVEDFEARGSRFSKSADERQRMLVQRKDELLQQARKRFLNK
-
-
-
-
Indications d'application
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
AMFR Blocking Peptide, (ABIN938287), is also available for use as a blocking control in assays to test for specificity of this AMFR antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of AMFR antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- AMFR (Autocrine Motility Factor Receptor (AMFR))
-
Autre désignation
- AMFR
-
Sujet
- Autocrine motility factor is a tumor motility-stimulating protein secreted by tumor cells. AMFR is a glycosylated transmembrane protein and a receptor for autocrine motility factor. The receptor, which shows some sequence similarity to tumor protein p53, is localized to the leading and trailing edges of carcinoma cells.
-
Poids moléculaire
- 53 kDa (MW of target protein)
-
Pathways
- ER-Nucleus Signaling
Antigène
-